Finance

Beta
Lists
IRTC:NASDAQ
iRhythm Holdings, Inc
$108.10
+0.70%
(+0.76) 1D
$108.10
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRTC...
Open
$109.00
High
$109.59
Low
$106.12
Mkt. cap
3.55B
Avg. vol.
570.73K
Volume
556.01K
52-wk high
$210.01
52-wk low
$101.75
EPS
-$0.86
Beta
1.27
Shares outstanding
32.86M
No. of employees
2K
Open
$109.00
High
$109.59
Low
$106.12
Mkt. cap
3.55B
Avg. vol.
570.73K
Volume
556.01K
52-wk high
$210.01
52-wk low
$101.75
EPS
-$0.86
Beta
1.27
Shares outstanding
32.86M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 13 analysts giving stock ratings to IRTC in the past 3 months
Strong Buy
Buy
12
Hold
1
Sell
0
12 month forecast
Based on 13 Wall Street analysts offering 12 month price targets for IRTC in the last 3 months.
Highest
Current $108.10
$255.00 (+135.88%)
Average
$177.36 (+64.06%)
Lowest
$147.00 (+35.98%)
News stories
From sources across the web
About iRhythm Holdings, Inc
CEO-
Employees2.4K
Founded2006
HeadquartersSan Francisco, California, United States
SectorMedical device
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.35 / -$0.64
+45.29%beat
Revenue / Est. (USD)
199.39M / 194.09M
+2.73%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
186.69M
192.88M
208.89M
199.39M
Cost of goods sold
53.83M
55.76M
60.84M
58.04M
Cost of revenue
53.83M
55.76M
60.84M
58.04M
Research and development expenses
21.01M
21.03M
21.05M
21.36M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
122.50M
120.09M
118.24M
131.85M
Operating expense
143.51M
141.12M
139.29M
153.21M
Total operating expenses
197.34M
196.89M
200.12M
211.24M
Operating income
-10.65M
-4.00M
8.77M
-11.85M
Other non operating income
2.26M
578.00K
-97.00K
-284.00K
EBT including unusual items
-14.40M
-5.19M
6.03M
-13.43M
EBT excluding unusual items
-6.34M
-761.00K
10.68M
-10.55M
Income tax expense
-183.00K
24.00K
447.00K
500.00K
Effective tax rate
1.27%
-0.46%
7.42%
-3.72%
Other operating expenses
-
-
-
-
Net income
-14.22M
-5.21M
5.58M
-13.93M
Net profit margin
-7.62%
-2.70%
2.67%
-6.99%
Earnings per share
-0.32
-0.06
0.29
-0.35
Interest and investment income
5.32M
5.94M
5.34M
4.88M
Interest expense
-3.28M
-3.28M
-3.32M
-3.29M
Net interest expenses
2.04M
2.66M
2.02M
1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.24M
-2.33M
10.52M
-10.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more